Phase 2 Crohn's disease trials recruiting now

All Crohn's disease trials, every phase

Other phases for Crohn's disease

Phase 2 Crohn's disease trials

• A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
  NCT06764615 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 32 locations
• A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
  NCT07483073 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 140 locations
• A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
  NCT06226883 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 225 locations
• A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
  NCT07113522 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 132 locations
• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
  NCT07196722 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 370 locations
• A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
  NCT07483099 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 70 locations
• A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease
  NCT07403968 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
  NCT06233461 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 190 locations
• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
  NCT06637631 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 139 locations
• A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
  NCT06958536 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 66 locations
• Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease
  NCT07556718 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
  NCT03167437 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Autologous Stem Cell Transplant for Crohn's Disease
  NCT03219359 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Autologous Stem Cell Transplantation for Crohn's Disease
  NCT00692939 · Phase: Phase 1, Phase 2 · Ages: 10 Years to 60 Years · Sex: All (male and female) · 2 locations
• Beta-Hydroxybutyrate Feasibility Treating IBD
  NCT06351124 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease
  NCT07078994 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 20 locations
• Clostridium Butyricum in Stenosing Crohn's Disease
  NCT07263880 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Patients
  NCT06953791 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease
  NCT06918808 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 5 locations
• DB-3Q for the Treatment of Medically Refractory Crohn's Disease
  NCT07625293 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Dose Escalation of Allogeneic Adipose Derived Stroma/Stem Cells for the Treatment of Crohn's Fistula
  NCT06636032 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
  NCT06456593 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 149 locations
• Evaluation of Local Co-administration of Autologous ADIpose Derived Stromal Vascular Fraction With Microfat for Refractory Perianal CROHN's Fistulas.
  NCT04010526 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients
  NCT06604260 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease
  NCT06606808 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• HB-adMSCs for the Treatment of Crohn's Disease
  NCT07077746 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease
  NCT07300553 · Phase: Phase 2 · Ages: 18 Years to 50 Years · Sex: All (male and female) · 2 locations
• Low Dose IL-2 for the Treatment of Crohn's Disease
  NCT04263831 · Phase: Phase 1, Phase 2 · Ages: 12 Years to 80 Years · Sex: All (male and female) · 3 locations
• MSC Intratissular Injection in Crohn Disease Patients
  NCT03901235 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Microbial Restoration in Inflammatory Bowel Diseases
  NCT04970446 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial)
  NCT07582458 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 4 locations
• Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
  NCT06976853 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 3 locations
• NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease
  NCT07683325 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease
  NCT05599347 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Precise Infliximab Exposure and Pharmacodynamic Control
  NCT05660746 · Phase: Phase 2, Phase 3 · Ages: 6 Years to 22 Years · Sex: All (male and female) · 11 locations
• Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
  NCT01962415 · Phase: Phase 2 · Ages: 2 Months to 55 Years · Sex: All (male and female) · 2 locations
• Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases
  NCT04924270 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 4 locations
• Standardized Microbiota Transplant Therapy in Crohn's Disease
  NCT06631586 · Phase: Phase 2 · Ages: 18 Years to 89 Years · Sex: All (male and female) · 3 locations
• Stem Cell Transplantation in Crohn's Disease
  NCT04224558 · Phase: Phase 1, Phase 2 · Ages: 13 Years to 28 Years · Sex: All (male and female) · 1 location
• Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
  NCT07697456 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 68 locations
• Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
  NCT06548542 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 255 locations
• Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease
  NCT06925061 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• Tolerance of Local Administration of Cryopreserved Autologous Stromal Vascular Fraction Combined With Micrograft for the Treatment of Refractory Ano-perineal Fistulas in Crohn's Disease
  NCT07629245 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Treatment of Moderate to Severe Refractory Crohn's Disease
  NCT06721962 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 13 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.